banner
Inquiry

Liposomes

Cat. No. Product Name Inquiry
X26-05-ZQ1080 Hydrolyzed pearl powder flexible nanoliposomes
X26-05-ZQ1081 Cucurbitacin liposomes
X26-05-ZQ1082 Adefovir dipivoxil liposomes
X26-05-ZQ1083 Palmitoyl pentapeptide-4 flexible liposomes
X26-05-ZQ1084 Levamlodipine besylate liposomes
X26-05-ZQ1085 Chitosan-modified chlorogenic acid liposomes
X26-05-ZQ1086 Polygonum cuspidatum resveratrol liposomes
X26-05-ZQ1087 Tramadol PEG2000-modified multivesicular liposomes
X26-05-ZQ1088 Peptide-modified liposomes (P1c LPs)
X26-05-ZQ1089 Amikacin sulfate multivesicular liposomes (AMK-MVLs)
X26-05-ZQ1090 α-Asarone proliposomes
X26-05-ZQ1091 Dehydrosilibinin-phospholipid complex liposomes
X26-05-ZQ1092 Artesunate-bortezomib liposomes
X26-05-ZQ1093 Teniposide long-circulating cationic liposomes
X26-05-ZQ1094 VHPK peptide-modified fluorescent nanoliposomes
X26-05-ZQ1095 R8-modified daunorubicin hydrochloride/honokiol liposomes
X26-05-ZQ1096 Cisplatin sustained-release multivesicular liposomes
X26-05-ZQ1097 Lidocaine hydrochloride transmembrane peptide polymer nanoliposomes
X26-05-ZQ1098 Oxotitanium porphyrin complex-folate liposomes
X26-05-ZQ1099 Peptide-modified gambogic acid-loaded liposomes
X26-05-ZQ1100 Tyroserleutide multivesicular liposomes
X26-05-ZQ1101 Neostigmine methylsulfate multivesicular liposomes (NB-MVL)
X26-05-ZQ1102 Ropivacaine hydrochloride multivesicular liposomes (RP-MVL)
X26-05-ZQ1103 N-Trimethyl chitosan-coated silibinin liposomes (TMC-SLBL)
X26-05-ZQ1104 Bupivacaine multivesicular liposomes (MVL)
X26-05-ZQ1105 Bulleyaconitine A multivesicular liposomes
X26-05-ZQ1106 DSPE-PEG-cholic acid-modified liposomes (CA-LP-DOX/silybin)
X26-05-ZQ1107 Novel porphyrin-liposome derivatives
X26-05-ZQ1108 LXT-101 multivesicular liposomes (DepoLXT-101)
X26-05-ZQ1109 TMC60-coated vitamin A cationic liposomes
X26-05-ZQ1110 Curcumin and paclitaxel liposomes (CUR-PTX LPs)
X26-05-ZQ1111 Resveratrol-epigallocatechin gallate liposomes (EGCG LPs)
X26-05-ZQ1112 Poly(2-ethyl-2-oxazoline)-cholesteryl chloroformate-modified doxorubicin hydrochloride liposomes
X26-05-ZQ1113 Sialic acid-modified chlorogenic acid liposomes (CA-SA LPs)
X26-05-ZQ1114 Cell-penetrating peptide TAT and cleavable PEG co-modified liposomes (C-TAT LPs)
X26-05-ZQ1115 ATF24 peptide-modified β-elemene liposomes (ATF24-PEG-β-E LPs)
X26-05-ZQ1116 Cytarabine multivesicular liposomes
X26-05-ZQ1117 Palmatine hydrochloride nano-flexible liposomes
X26-05-ZQ1118 PEG-DSPE modified doxorubicin hydrochloride liposomes (PEOZ-DOX LPs and PEG-DOX LPs)
X26-05-ZQ1119 Dual-functional RGD-TAT peptide-modified liposomes (RGD-TAT LPs)

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.